New pharmacological strategies for pain relief

References

• Analgesics: From Chemistry and Pharmacology to clinical application. Buschmann H, Christoph T, Friderichs E, Maul C, Sundermann B (Fils), Wiley VCH Weinheim, Germany (In Press).
   Google Scholar
• ••This book gives a comprehensive review of current molecular approaches and compounds.
   Google Scholar
• Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant sodium channel expressed by C-fibre associated sensory neurons. Nature 379, 257–262 (1996).
   Google Scholar
• Chen C-C, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377,428–431 (1995).
   Google Scholar
• Lembo PM, Grazzini E, Groblewski T et al Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat. Neurosci. 5,201–209 (2002).
   PubMed Web of Science ®Google Scholar
• Bonini JA, Jones IKA, Adham N et al Identification and characterization of two G-protein coupled receptors for neuropeptide FE I Biol. Chem. 15,39324–39231 (2000).
   Google Scholar
• Elshourbagy NA, Ames RS, Fitzgerald LR et al Receptor for the pain modulatory neuropeptides FF and AF is an orphan G-protein coupled receptor.' Biol. Chem. 275,25965–25971(2000).
   Web of Science ®Google Scholar
• Kaupmann K, Huggel K, Heid J et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature386, 223–224 (1997).
   PubMedGoogle Scholar
• Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin-receptor: a heat-activated ion channel in the pain-pathway. Nature389, 816–824 (1997).
   PubMed Web of Science ®Google Scholar
• ••Describes the cloning and characterizationof the long-awaited capsaicin-receptor: a major breakthrough of nociceptor biology.
   Google Scholar
• Wahlestedt C, Salmi P, Good L et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl Arad Sc]. USA 97,5633–5638 (2000)
   PubMed Web of Science ®Google Scholar
• Lai J, Gold MS, Kim CS et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain 95,143–152 (2002).
   Google Scholar
• •Convincing validation of the Na± channel NaV1.8. using intrathecally given antisense oligonucleotides.
   Google Scholar
• Edsall SA, Knapp RJ, Vanderah TW, Roeske WR, Consroe P, Yamamura HI. Antisense oligonucleotide treatment to the brain cannabinoid receptor inhibits antinociception. Neuroreport 31,593–596 (1996).
   Google Scholar
• Bevan S. In: Textbook of Pain. Wall PD, Melzack R (Eds), Churchill-Livingstone, New York, USA (1999)
   Google Scholar
• Woolf CJ, Salter MW Neuronal plasticity: increasing the gain in pain. Science 288, 1765–1769 (2000).
   PubMed Web of Science ®Google Scholar
• Gold MS, Levine JD, Correa AM. Modulation of TTX-R 'Na by PKC and and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. .1. NeuroscL 18,10345–10355 (1998).
   Google Scholar
• Xu GY, Huang LY, Zhao ZQ. Activation of silent mechanoceptive cat C and A sensory neurons and their substance P expression following peripheral inflammation. J. Physiol 528,339–348 (2000).
   Google Scholar
• Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis. 8,1–10 (2001)
   PubMed Web of Science ®Google Scholar
• Michael GJ, Averill S, Nitjunan A et al. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J. NeuroscL 17,8476–8490 (1997).
   PubMed Web of Science ®Google Scholar
• Melzack R, Wall PD. Pain mechanisms: a new theory. Science 150,971–979 (1960).
   Google Scholar
• Millan MM. Descending control of pain. Pmg. Neurobiol 66,355–474 (2002).
   PubMed Web of Science ®Google Scholar
• Mollereau C, Parmentier M, Mailleux P et al ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341, 33–38 (1994).
   Google Scholar
• Meunier JC, Mollereau C, Toll L et al. Isolation and structure of the endogenous agonist of the opioid receptor-like ORL1 receptor. Nature 377,532–535 (1995).
   PubMed Web of Science ®Google Scholar
• Reinscheid RK, Nothacker HP, Bourson A et al Orphanin FQ. A neuropeptide that activates an opioid like G-protein coupled receptor. Science 270,792–794 (1995).
   Google Scholar
• Barlocco D, Cignarella G, Giardina GAM, Toma L. The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesics. Eur. Merl Chem. 35,275-282 (2000).
   Google Scholar
• Shinkai H, Ito T, Iida T, Kitao Y, Yamada H, Uchida I. 4-Aminoquinolines: Novel nociceptin antagonists with analgesic activity. J. Med. Chem. 43,4667-4677 (2000).
   Google Scholar
• Stein C. Peripheral analgesic actions of opioids. .1. Pain Symptom. Manage. 6,119-124 (1991).
   Google Scholar
• Stein C, Cabot PJ, Schafer M. Peripheral opioid analgesia: Mechanisms and clinical implications. In: °plaids in pain control. Basic and clinical aspects. Stein C (Ed.), Cambridge University Press, Cambridge, UK (1999).
   Google Scholar
• Sander-Kiesling A, Pan HL, Chen SR et al. Effect of kappa agonists on visceral nociception induced by uterine cervical distension in rats Pain 96,13–22 (2002).
   Google Scholar
• Joshi GP. Propiram Shire. Drugs, 5,281-285 (2002).
   Google Scholar
• Buschmann H, Sundermann B, Maul C. p- Selektive Opioide ohne Morphinanstruktur. Pharm. L u. Zeit 31, 44–50 (2002).
   Google Scholar
• West WL, Yeomans DC, Proudfit HK. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res. 626,127–135 (1993).
   Google Scholar
• Willis WD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. I Gun. Neurophysiol 14,2–31 (1997).
   PubMed Web of Science ®Google Scholar
• Curatolo M, Petersen-Felix S, Arendt- Nielsen L, Zbinden AM. Epidural adrenaline and clonidine: segmental analgesia and effects on different pain modalities. Anesthesiology87, 785–794 (1997).
   PubMed Web of Science ®Google Scholar
• Onttonen T, Pertovaara A. The mechanical antihyperalgesic effect of intrathecally administered MPV-2426, a novel alpha2- adrenoceptor agonist, in a rat model of postoperative pain. Anesthesiology 92, 1740–1745 (2000).
   PubMed Web of Science ®Google Scholar
• Daly JW Adenosine receptors: Targets for future drugs. J. Med. Chem. 25,197–207 (1982).
   PubMedGoogle Scholar
• Salter MW, Sollevi A. Roles of purines in nociception and pain. Handbook Exp. Pharmacol 371–401 (2001).
   Google Scholar
• Sullivan JM. Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn. Nkm. 7,132–139 (2000).
   Google Scholar
• Mao J, Chen L. Gabapentin in pain management. Anesth. Anal& 91,680–687 (2001).
   Google Scholar
• Hemstreet B, Lapointe M. Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy. Gun. Ther. 23,520–531 (2001).
   Google Scholar
• Rice ASC, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double-blind, placebo-controlled study. Pain 94,215–224 (2001).
   PubMed Web of Science ®Google Scholar
• Alden KJ, Garcia J. Differential effect of gabapentin on neurnal and muscle calcium currents. .1. Pharmacol Exp. Ther 297, 727–735 (2001).
   Google Scholar
• Martin L, Rabasseda X, Leeson J, Castaner J. Pregabalin. Drugs Fut. 24,862–870 (1999).
   Google Scholar
• Rostock A, Rundfeldt C, Bartsch R. Effects of the anticonvulsant retigabine in neuropathic pain models in rats. Poster presentation, 41st Annual Meeting of the German Society of Pharmacology and Toxicology (2000).
   Google Scholar
• Main MJ, Cryan JE, Dupere JRB, Cox B, Clare JJ, Burbidge SA. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mal Pharmacol 58,253–262 (2000).
   PubMed Web of Science ®Google Scholar
• Rundfeldt C, Netzer R. The novel anticonvulsant retigabine activates M-current in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits. NeuroscL Lett. 282,73–76 (2000).
   PubMed Web of Science ®Google Scholar
• Wickenden AD, Yu W, Zou A, Jegla T, Wagoner PK. Retigabine, a novel anticonvulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 58,591–600 (2000).
   Google Scholar
• Tatulian L, Delmas P, Abogadie FC, Brown DA. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anticonvulsant drug retigabine. j Neumsci. 21,5535–5545(2001).
   Google Scholar
• Robbins J. KCNQ potassium channels: physiology, pathophysiology and pharmacology. Pharmacol Ther. 90, 1–19 (2001).
   PubMed Web of Science ®Google Scholar
• Szallasi A, Blumberg PM. Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res. 524, 106–111 (1990).
   PubMed Web of Science ®Google Scholar
• Hayes P, Meadows HJ, Gunthorpe MJ et al Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain 88, 205–215 (2000).
   PubMed Web of Science ®Google Scholar
• Wood JN (Ed.). Capsaicin in the Study of Pain. Academic Press, New York, USA (1993).
   Google Scholar
• Szallasi A, Blumberg PM. Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules). Adv. Pharmacol 24, 123–155 (1993).
   PubMedGoogle Scholar
• Winter J, Bevan S, Campbell EA. Capsaicin and pain mechanisms. BE j Anaesthesia 75, 157–168 (1993).
   Google Scholar
• Walker K, Gentry C, Medhurst S etal. Capsazepine shows species selective antihyperalgesic effects in models of chronic inflammatory and neuropathic pain. Soc. Neurosci. Abstr 926.7 (2001)
   Google Scholar
• Julius D, Basbaum AI, Molecular mechanisms of nociception. Nattily 413, 203–210 (2001).
   Google Scholar
• ••Outstanding review covering themolecular basis of pain perception in the nociceptor.
   Google Scholar
• Mantyh PW, Rogers SD, Honore P et al Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance Preceptor. Science 278, 275–279 (1997).
   PubMed Web of Science ®Google Scholar
• •First description of analgesia by selective ablation of spinal neurons.
   Google Scholar
• Nichols ML, Allen BJ, Rogers SD et al Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286,1558–1561 (1999).
   PubMed Web of Science ®Google Scholar
• Kurreck J, Wyszko E, Gillen C, Erdmann VA. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucl. Acids Res. 30, 1911–1918 (2002).
   PubMed Web of Science ®Google Scholar
• Stark S, Helmling S, Maasch C et al. CGRP binding Spiegelmers: A new therapeutic approach for migraine. AbstE Soc. Neumsci. 218.7 (2002)
   Google Scholar
• Stark S, Faulhammer D, Eschgfäller B et al. Nociceptin/Orphanin FQ binding Spiegelmers (L-RNA): A new pharmacological tool for studying nociceptin effects. Abstr IASP World Congmss on Pain (2002).
   Google Scholar
• Finegold AA, Mannes AJ, Iadarola MJ. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum. Gene Ther 10, 1251–1257 (1999).
   Google Scholar
• Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc. Natl Acad. Li. USA 96, 3211–3216 (1999).
   PubMed Web of Science ®Google Scholar
• Braz J, Beaufour C, Coutaux A et al Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. Neurosci 21, 7881–7888 (2001).
   PubMed Web of Science ®Google Scholar
• Goss JR, Mata M, Goins WF, Wu IIf I, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 8,551–556 (2001).
   Google Scholar
• Woolf CJ, Decosterd I. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain Suppl 6, S141—S147 (1999).
   Google Scholar
• ••Stimulating article about the implicationsof a mechanism-based classification of pain for future treatment.
   Google Scholar
• Dallel R, Voisin D. Towards pain treatment based on the classification of pain-generating mechanisms? Eur. Nemo'. 45, 126–132 (2001).
   Google Scholar
• •Presents diagnostic methods that may help to identify the mechanisms underlying chronic pain.
   Google Scholar
• Woolf CJ, Max M. Mechanism-based pain diagnosis. Anesthesia 95, 241–249 (2001).
   Google Scholar
• Silverfield JC, Kamin M, Wu SC, Rosenthal N. Tramadol/acetaminophen combination tablets for the reatment of osteoarthritis flare pain: a multicenter, out-patient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin. Ther. 24, 282–297 (2002).
   PubMed Web of Science ®Google Scholar
• www.od.nih.gov/oba/rac/clinicaltrial.htm Interesting report of the US recombinant DNA advisory committee listing human gene therapy protocols.
   Google Scholar